Oral Antiseptics Market

Market Overview

The global oral antiseptics market size was valued at USD 2.49 billion in 2022. It is estimated to reach USD 3.82 billion by 2031, growing at a CAGR of 4.90% during the forecast period (2023–2031). The increasing accessibility of various product categories and the efficacy of oral antiseptics derived from herbs and essential oils have prompted consumers to favor them over alcohol-based oral antiseptics, hence propelling the global market.

Oral antiseptics are primarily used to prevent the action or growth of harmful microorganisms, either by inhibiting the activity of harmful microbes or reducing their load from the oral environment by killing them. Oral antiseptics are widely used to decrease the number of microbes in the oral cavity before and during a dental care procedure and supplement mechanical plaque control. Utilizing oral antiseptics is an optimal approach to cleansing the oral cavity with a proper antiseptic solution before and during various dental operations, such as oral surgery.

Oral antiseptics decrease the amount of potential disease-causing microorganisms and create a more hygienic environment in the mouth. This is crucial in preventing the occurrence of bacteria in the bloodstream caused by dental operations. Oral antiseptics are available in both gel and liquid formulations.

Market Dynamics

Global Oral Antiseptics Market Drivers

Rising Online Sales of Oral Antiseptics

The e-commerce industry acts as a potential platform for trade activities, which is expected to bolster the demand for various products in the market. In this scenario, online sales channels have proved to be a significant option for patients. Therefore, several companies are investing in initiatives to expand their business segments and cater to changing consumer requirements. Hence, online sales have revolutionized the market.

Online sales channels are the latest sales avenues for prescription and OTC drugs. There has been a considerable rise in the availability of alcohol-free and natural oral antiseptic products manufactured using essential oils and herbal extracts. The American Dental Association (ADA) has approved a few oral antiseptic products for OTC sales in the US. Many OTC oral antiseptic products have surged through online distribution channels in Asia-Pacific, Europe, and LAMEA. Such factors propel oral antiseptics market growth.

Shift Toward Alcohol-free Oral Antiseptics

Alcohol-containing oral antiseptics are known to have many side effects and, therefore, may irritate the periodontitis tissue. However, cetylpyridinium chloride, chlorhexidine gluconate, povidone-iodine, hydrogen peroxide, and essential and herbal oils-based oral antiseptics have demonstrated exceptional efficacy. Most alcohol-based oral antiseptics are marketed as ethanol-based products with a 20% concentration. However, a 20% concentration is insufficient to treat tooth caries and bad odor-causing bacteria. Therefore, several doctors, dentists, and pharmacists prefer alcohol-free oral antiseptics. Alcohol-free oral antiseptics offer several benefits and are relatively more effective than alcohol-based oral antiseptics. Dryness in the mouth is one of the major side effects of alcohol-based oral antiseptics.

Furthermore, Cetylpyridinium chloride-based oral antiseptics kill bacteria that cause bad breath, plaque, and caries. Chlorhexidine gluconate is mostly used to control gingivitis, while hydrogen peroxide kills oral bacteria, whitens teeth, and reduces oral cavities. Likewise, several natural ingredients, such as essential oils (thymol, eucalyptus, menthol peppermint, and tea tree oils), are relatively more effective than other alternatives due to zero side effects and good pain relief. Herbal ingredients are also effective and offer better relief from dental conditions than other alcohol-free oral antiseptics. Herbal ingredients are better for dental caries, periodontitis, gingivitis, bad breath, gum problems, tooth whitening, and oral cavities. The rise in the availability of different product types and the effectiveness of herbal and essential oils-based oral antiseptics have encouraged consumers to prefer them over alcohol-based oral antiseptics.

Global Oral Antiseptics Market Restraint

Side-Effects Associated with Oral Antiseptics

Oral antiseptics have several side effects, such as allergic reactions, which include rashes, itching or swelling, severe dizziness, and breathing issues. Most of these products are liquid, so users must take appropriate doses and avoid ingesting them. Other side effects of oral antiseptics include redness, irritation, and stinging on the application site. Although oral antiseptics do not cause serious allergies, users must take precautions to avoid side effects associated with inactive ingredients in these products. Overdoses of oral antiseptics may also cause breathing issues or poisonous reactions. The excessive use of oral antiseptics/ oral antiseptic mouth rinses may contribute to cardiovascular events in patients with cardiovascular conditions, as the inhabitancy of nitrite leads to high blood pressure.

Global Oral Antiseptics Market Opportunities

Growing Awareness of Oral and Dental Care

Good oral health is key to preventing several illnesses and maintaining overall good health and hygiene. Thus, good dental or oral care must entail hygiene practices such as regular brushing and interdental cleaning to care for teeth, gums, and bad breath and prevent numerous diseases. Most oral problems, such as bad breath (halitosis), dental caries, and periodontal diseases, originate from teeth and gums. Gum diseases cause tooth loss, cavities, infection, and other serious conditions. The transition from basic mouth care to holistic dentistry treatments drives the demand for several oral care products, such as oral antiseptics.

Furthermore, the increasing prevalence of oral and maxillofacial surgeries drives the demand for oral antiseptics. Several oral surgical procedures require preoperative and post-operative oral antiseptics during and after surgeries. Common surgical procedures such as wisdom teeth removal, dental implants, corrective jaw surgeries, facial and mouth trauma surgeries, bone grafting, snap-on dentures, and full-arch dental implants require the usage of oral antiseptics.

Moreover, the rise in the number of oral surgeons worldwide will directly impact the use of oral antiseptics. During the epidemic, over 7500 oral surgeons in the US donated their services. In the US, over 94% of these oral surgeons are self-employed. The total number of dentists in the US was 201,117 in 2019. The growing interest in dental education is expected to change their healthcare services. This is predicted to create opportunities for market growth over the forecast period.

Regional Analysis

Europe Dominates the Global Market

Based on region, the global oral antiseptics market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Europe is the most significant global oral antiseptics market shareholder and is anticipated to exhibit a CAGR of 4.20% during the forecast period. The aging population, increased demand for sophisticated dental operations, and rising government spending on oral health throughout Europe are some factors propelling the market's expansion. Moreover, the market would be driven throughout the projected period by the availability of comparatively better dental care reimbursement programs compared to other areas. According to estimates, almost 15% of Europeans are 65 or older. The region's aging population is more likely to experience oral issues, which has increased the demand for dental procedures.

Furthermore, the population of Europe has a higher prevalence of dental caries. The disease continues to be an issue for many people in Eastern Europe and those from socioeconomically disadvantaged groups in all of the European Union's member states. The prevalence of periodontitis rises to 70–85% in the elderly population (60–65 years) in Europe, where more than 50% of the population may have some form of the condition and more than 10% have severe disease. The prevalence of severe periodontitis is 5% -20 % in Europe's middle age segment (34–44). Moreover, the rise in oral cancer cases and a prevalence rate of 5–10 cases per 100,000 people will accelerate the demand for oral and dental surgeries, driving the demand for oral antiseptic solutions in Europe.

North America is estimated to exhibit a CAGR of 4.35% over the forecast period. The region has the second-highest revenue share in the global oral antiseptics market. This is mainly due to the growing volume of dental procedures, especially to restore aesthetic appeal among older people. The surge in the volume of surgeries and market growth is because of the availability of advanced dental and oral care infrastructure, constant technological innovations, and growing awareness of various treatment options.

In North America, around 42% of children aged between 2 and 11 with primary teeth, as well as black and Hispanic children, are prone to tooth decay. As per the American Public Health Association, Americans spend around USD 3 billion yearly to remove 10 million wisdom teeth. The growing geriatric population, the rising number of edentulous people, the increasing awareness about oral health, the growing adoption of advanced digital dentistry procedures, and the increasing partnership between market players and distributors will drive the oral antiseptics market in North America during the forecast period.

The Latin American oral antiseptics market is expanding quickly and is anticipated to continue expanding at a similar rate over the coming years. Latin America is a developing region, with countries like Brazil, Mexico, and Argentina witnessing relatively faster growth than developed economies. Factors such as the growing presence of dental practices, burgeoning medical tourism, and the rising number of dentists drive market growth. Brazil's dentists account for around 20% of the global dental population. Increasing health insurance coverage and government support for overall healthcare will create new opportunities for market players.

Segmental Analysis

The global oral antiseptics market is segmented by chemical composition, application, form, and distribution channel. 

Based on chemical composition, the global market can be segmented by chlorhexidine gluconate, herbal and essential oils, cetylpyridinium chloride, and others. 

The Chlorhexidine gluconate-based oral antiseptics segment dominates the market and is expected to exhibit a CAGR of 4.94% over the forecast period. The global burden of dental diseases and oral surgeries has grown significantly yearly. The growing need for oral surgeries among the adult and geriatric populations, the rising prevalence of dental caries, and the increasing adoption of oral hygiene practices and initiatives for oral care have triggered CHG-based oral antiseptics. Dentists prescribe most CHG-based oral antiseptics, while some are available over the counter due to high safety and fewer side effects. Moreover, the popular trend of e-commerce has supported the growth of the CHG-based oral antiseptics segment.

Based on application, the global market is segmented into treatment and prevention.

The treatment segment owns the highest market share and is projected to exhibit a CAGR of 4.86% over the forecast period. The increasing number of dental procedures is boosting the treatment segment as there is a direct impact on the use of oral antiseptics due to the surge in the number of dental and oral surgeries. Oral diseases are a major healthcare burden that impacts people worldwide. It frequently leads to gum bleeding, pain, physical deformity, and sometimes fatal outcomes. High-income countries are witnessing a high prevalence of oral conditions, as evidenced by the expenditure on oral disorders, which accounts for around 5% of the healthcare expenditure.

In North American and European countries, the high prevalence of oral cancer and diabetes has contributed to the surge in dental caries and halitosis, accelerating the use of oral rinses for oral cleansing. Some oral and dental disorders, such as oral malodor, plaque, and gingivitis, require oral cleaning treatments. Tooth decay and periodontal disorders also require tooth whitening procedures, which has propelled the use of oral antiseptics for oral cleansing. Moreover, dental practices majorly drive the oral antiseptics market for oral care treatments. In 2020, there were 189,040 and 12,010 dental practices in the US and the UK, respectively.

Based on form, the global oral market is segmented into solution- and gel-based oral antiseptics. 

The solution-based oral antiseptics segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 5.01% throughout the forecast period. The solution-based form of oral antiseptics dominates the major market share over the gel form due to its high efficacy rate and acceptance compared to the gel-based form. Numerous chemical-based oral antiseptics solutions are available by prescription, over-the-counter, and other online platforms, which drives the segment's growth. Similarly, solution-based oral care solutions are used to treat oral conditions and as a preventive measure per a dentist's suggestions. The solution-based oral antiseptics are widely used in pre- and post-surgical dental procedures to reduce oral microbats and prevent post-surgical complications. These factors will likely drive the demand for solution-based oral antiseptics.

Based on distribution channels, the market is segmented into drug stores and standalone retail pharmacies, e-commerce, and others. 

The drug stores and standalone retail pharmacies segment owns the largest market share and is expected to exhibit a CAGR of 4.93% throughout the forecast period. These are the most effective distribution channels for oral antiseptics due to their easy accessibility in most urban and rural areas. The high prevalence of dental and oral conditions is mostly in urban areas. Moreover, the widespread availability of dental care services and promotional campaigns significantly contribute to the increased sales of oral antiseptics in retail pharmacies. The rise in dental spending on oral care directly contributes to the increase in sales of oral antiseptics sold through retail pharmacies. Prior to the COVID-19 pandemic, the absence of limitations on in-person product purchases had played a role in the expansion of retail distribution channels for oral antiseptics.

Recent Developments

• December 2022- Colgate-Palmolive was named to the Dow Jones Sustainability Indices for the sixth consecutive year and CDP's Climate Change and Water Security A Lists for the third year running. These achievements recognize Colgate's ongoing commitment to sustainability leadership, sustainable business practices, and transparency about its sustainability efforts.
• November 2023- Herbarom introduced its new line of natural solid toothpaste and mouthwash at the Cosmetic 360 event.